Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Argus Health
Chubb
Healthtrust
Teva
Federal Trade Commission
US Department of Justice
Cantor Fitzgerald

Generated: August 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021278

« Back to Dashboard

NDA 021278 describes FOCALIN, which is a drug marketed by Novartis and is included in two NDAs. It is available from two suppliers. There are two patents protecting this drug and eight Paragraph IV challenges. Additional details are available on the FOCALIN profile page.

The generic ingredient in FOCALIN is dexmethylphenidate hydrochloride. There are six drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the dexmethylphenidate hydrochloride profile page.
Summary for 021278
Tradename:FOCALIN
Applicant:Novartis
Ingredient:dexmethylphenidate hydrochloride
Patents:0
Pharmacology for NDA: 021278
Medical Subject Heading (MeSH) Categories for 021278
Suppliers and Packaging for NDA: 021278
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FOCALIN dexmethylphenidate hydrochloride TABLET;ORAL 021278 NDA Novartis Pharmaceuticals Corporation 0078-0380 N 0078-0380-05
FOCALIN dexmethylphenidate hydrochloride TABLET;ORAL 021278 NDA Novartis Pharmaceuticals Corporation 0078-0381 N 0078-0381-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Nov 13, 2001TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Nov 13, 2001TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Nov 13, 2001TE:ABRLD:Yes

Expired US Patents for NDA 021278

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis FOCALIN dexmethylphenidate hydrochloride TABLET;ORAL 021278-003 Nov 13, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FOCALIN dexmethylphenidate hydrochloride TABLET;ORAL 021278-003 Nov 13, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FOCALIN dexmethylphenidate hydrochloride TABLET;ORAL 021278-002 Nov 13, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FOCALIN dexmethylphenidate hydrochloride TABLET;ORAL 021278-002 Nov 13, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FOCALIN dexmethylphenidate hydrochloride TABLET;ORAL 021278-001 Nov 13, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FOCALIN dexmethylphenidate hydrochloride TABLET;ORAL 021278-002 Nov 13, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FOCALIN dexmethylphenidate hydrochloride TABLET;ORAL 021278-001 Nov 13, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Julphar
Harvard Business School
Johnson and Johnson
Argus Health
AstraZeneca
Dow
Covington
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.